These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18372441)

  • 21. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Appropriate administration of anticoagulants and antiplatelets].
    Wakisaka K; Yasaka M
    Nihon Rinsho; 2014 Jul; 72(7):1258-63. PubMed ID: 25163318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?
    Sudlow C
    CMAJ; 2005 Oct; 173(9):1024-6. PubMed ID: 16247094
    [No Abstract]   [Full Text] [Related]  

  • 24. Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation.
    Damani RH; Suarez JI
    South Med J; 2016 Nov; 109(11):721-729. PubMed ID: 27812719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stroke: Secondary prevention of ischemic events.
    Morris JG; Carter EL; Martin SA
    J Fam Pract; 2017 Jul; 66(7):420-427. PubMed ID: 28700757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs--is antiplatelet monotherapy still reasonable?
    Diener HC; Weber R; Weimar C; Röther J
    Int J Clin Pract; 2011 May; 65(5):531-5. PubMed ID: 21489077
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiplatelet treatment in the secondary prevention of coronary and cerebrovascular disease: is there any place for novel agents?
    Ntalas IV; Milionis HJ; Kei AA; Kalantzi KI; Goudevenos JA
    Angiology; 2014 Jul; 65(6):473-90. PubMed ID: 23966569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antithrombotic therapy in the secondary prevention of stroke].
    Mel'nikova EV; Kadinskaia MI; Gerasimenko DV; Shmonin AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):23-7. PubMed ID: 21626814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.
    Kapil N; Datta YH; Alakbarova N; Bershad E; Selim M; Liebeskind DS; Bachour O; Rao GHR; Divani AA
    Clin Appl Thromb Hemost; 2017 May; 23(4):301-318. PubMed ID: 27461564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke.
    Min J; Farooq MU
    Postgrad Med; 2016 Aug; 128(6):620-8. PubMed ID: 27263867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cerebral infarction and transient ischemic attack].
    Sahara N; Kuwashiro T; Okada Y
    Nihon Rinsho; 2016 Apr; 74(4):666-70. PubMed ID: 27333757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding risk assessment for stroke patients on antithrombotic therapy.
    Castilla-Guerra L; Fernández-Moreno MDC; de la Vega-Sánchez JM; Leon Jimenez D
    Clin Investig Arterioscler; 2019; 31(6):282-288. PubMed ID: 31005341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical Management for Secondary Stroke Prevention.
    Kim AS
    Continuum (Minneap Minn); 2020 Apr; 26(2):435-456. PubMed ID: 32224760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary prevention by stroke subtype: a nationwide follow-up study in 46 108 patients after acute ischaemic stroke.
    Kim D; Lee SH; Joon Kim B; Jung KH; Yu KH; Lee BC; Roh JK;
    Eur Heart J; 2013 Sep; 34(35):2760-7. PubMed ID: 23729692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary prevention after ischemic stroke.
    Jaff MR; White CJ
    N Engl J Med; 2012 Aug; 367(7):675-6; author reply 676-7. PubMed ID: 22894587
    [No Abstract]   [Full Text] [Related]  

  • 38. Secondary prevention after ischemic stroke.
    Zhang H; Messerli FH; Staessen JA
    N Engl J Med; 2012 Aug; 367(7):675; author reply 676-7. PubMed ID: 22894586
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter by Meves and Neubauer regarding article "Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack".
    Meves SH; Neubauer H
    Stroke; 2012 Nov; 43(11):e167; author reply e168. PubMed ID: 23091124
    [No Abstract]   [Full Text] [Related]  

  • 40. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.